JP2018534243A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018534243A5 JP2018534243A5 JP2018511611A JP2018511611A JP2018534243A5 JP 2018534243 A5 JP2018534243 A5 JP 2018534243A5 JP 2018511611 A JP2018511611 A JP 2018511611A JP 2018511611 A JP2018511611 A JP 2018511611A JP 2018534243 A5 JP2018534243 A5 JP 2018534243A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrv
- refers
- isomer
- compound
- certain embodiments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562214613P | 2015-09-04 | 2015-09-04 | |
| US62/214,613 | 2015-09-04 | ||
| PCT/US2016/050270 WO2017041040A1 (en) | 2015-09-04 | 2016-09-02 | Androgen receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018534243A JP2018534243A (ja) | 2018-11-22 |
| JP2018534243A5 true JP2018534243A5 (enExample) | 2019-12-12 |
| JP6933644B2 JP6933644B2 (ja) | 2021-09-08 |
Family
ID=58188655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511611A Expired - Fee Related JP6933644B2 (ja) | 2015-09-04 | 2016-09-02 | アンドロゲン受容体拮抗薬 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10428048B2 (enExample) |
| EP (1) | EP3350167A4 (enExample) |
| JP (1) | JP6933644B2 (enExample) |
| CN (1) | CN108349900A (enExample) |
| WO (1) | WO2017041040A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10654809B2 (en) | 2016-06-10 | 2020-05-19 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
| US10865184B2 (en) | 2015-04-21 | 2020-12-15 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
| WO2019023651A2 (en) * | 2017-07-28 | 2019-01-31 | Massachusetts Institute Of Technology | MODULATORS OF THE SMALL MOLECULE ANDROGEN RECEPTOR |
| WO2019032840A1 (en) * | 2017-08-09 | 2019-02-14 | Druggability Technologies Ip Holdco Limited | PHARMACEUTICAL COMPOSITION COMPRISING ABIRATERONE ACETATE AND DAROLUTAMIDE |
| JP2023520872A (ja) * | 2020-04-02 | 2023-05-22 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | ピラゾリルプロパンアミド化合物およびその前立腺がんを処置するための使用 |
| US12152035B2 (en) | 2020-12-30 | 2024-11-26 | Industrial Technology Research Institute | Androgen receptor binding molecule and use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH509382A (it) | 1967-06-23 | 1971-06-30 | Crc Ricerca Chim | Metodo per l'ottenimento dei colori pirolchinolici e dei loro sali derivati |
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US20080281105A1 (en) | 2005-01-18 | 2008-11-13 | Immusol Incorporated | Novel Quinolinium Salts and Derivatives |
| CN101106992A (zh) * | 2005-01-18 | 2008-01-16 | 伊姆索公司 | 新颖的喹啉鎓盐和衍生物 |
| WO2008128100A1 (en) * | 2007-04-13 | 2008-10-23 | The Regents Of The University Of California | Small-molecule inhibitors of the androgen receptor |
| EP2276345A4 (en) | 2008-04-24 | 2012-06-06 | Univ California | SMALL MOLECULAR INHIBITORS OF THE ANDROGEN RECEPTOR |
| KR102193461B1 (ko) * | 2014-04-24 | 2020-12-21 | 동아에스티 주식회사 | 퀴놀린계 화합물 및 이를 포함하는 선택적 안드로겐 수용체 효능제 |
-
2016
- 2016-09-02 US US15/757,238 patent/US10428048B2/en active Active
- 2016-09-02 CN CN201680064061.1A patent/CN108349900A/zh active Pending
- 2016-09-02 JP JP2018511611A patent/JP6933644B2/ja not_active Expired - Fee Related
- 2016-09-02 EP EP16843143.5A patent/EP3350167A4/en not_active Withdrawn
- 2016-09-02 WO PCT/US2016/050270 patent/WO2017041040A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018534243A5 (enExample) | ||
| JP2015063536A5 (enExample) | ||
| JP2014521688A5 (enExample) | ||
| JP2016537346A5 (enExample) | ||
| JP2016510323A5 (enExample) | ||
| JP2013063963A5 (ja) | 複素環化合物 | |
| JP2015532645A5 (enExample) | ||
| JP2018502909A5 (enExample) | ||
| JP2016505614A5 (enExample) | ||
| JP2016531126A5 (enExample) | ||
| JP2014043437A5 (ja) | 有機化合物 | |
| MX2018014164A (es) | Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico. | |
| WO2021111462A1 (en) | An improved process for the preparation of osimertinib mesylate | |
| RU2016148821A (ru) | Способ радиомечения | |
| JP2020502116A5 (enExample) | ||
| JP2013531021A (ja) | フェブキソスタットの結晶形ｉｉを調製するための方法 | |
| CN105237437B (zh) | 一种恩他卡朋杂质化合物及其制备方法 | |
| JP2013525473A5 (enExample) | ||
| CN103664931B (zh) | 一种含苯并噻唑环和咪唑环希夫碱化合物及其制备方法 | |
| CN102850282A (zh) | 3－烷氧基取代－2－吡嗪甲酰氨类化合物及其用途 | |
| CN111989335A (zh) | 膦酰胺酯化合物及其盐和相关晶体形式、制备方法和用途 | |
| JP2017511361A5 (enExample) | ||
| EP3242876A1 (en) | An improved process for the preparation of lurasidone and its intermediate | |
| CN111247160A (zh) | 一种胆酸类化合物的制备方法 | |
| Sheibani | Regioselective combination of 1, 3-dinucleophiles such as 2-mercaptobenzimidazole, 5-mercapto-3-phenyltriazole and potassium thiocyanate with 2, 2-dicyanooxiranes |